Table 1.
EMQ | n | WUSCE | n WUSCE | ||
---|---|---|---|---|---|
% failed | EMQ | % failed | WUSCE | Comparison* | |
EMQ 1 and WUSCE 5– Contra-indications in the use anti-coagulants and antibiotics | 65.7% | 35 | 68.0% | 20 | 6 |
EMQ 2 and WUSCE 3– Anti-coagulants and analgesia in the post-operative patient | 66.7% | 42 | 61.1% | 25 | 7 |
EMQ 3 and WUSCE 4– Diverticular disease; i.v. administration of antibiotics and fluids | 51.0% | 49 | 26.9% | 21 | 19 |
EMQ 4 and WUSCE 6– Respiratory; chronic obstructive pulmonary disease | 56.7% | 30 | 40.0% | 18 | 8 |
EMQ 5– Diabetes; insulin selection | 75.0% | 28 | – | – | – |
EMQ 6 and WUSCE 2– Analgesia in emergency medicine | 57.7% | 26 | 70.3% | 33 | 5 |
WUSCE 1– Renal failure; fluid management and arteriopathy | – | – | 61.7% | 44 | – |
Table 1 shows how the EMQs and WUSCEs relate to each other in terms of the medical domain they assess. The values are the percentage of the FY1s completing each assessment item who were deemed to have failed the item (EMQ and WUSCE). It also shows the number of FY1s who actually completed each of the items.
The number of individual FY1 doctors who completed both the WUSCE and EMQ and were therefore available for Spearman Rho correlation analysis.